August 28, 2014
REDWOOD CITY, Calif. - August 28, 2014 - HeartFlow, Inc. today announced the recent appointment of several key executives including Baird Radford, as chief financial officer; Brent Ness, as chief commercial officer; Robert Eno, as vice president of marketing; and Yoshiki Kawabata, as president of HeartFlow Japan GK.
“This team shares broad experience and significant track records of success in bringing to market some of our era’s most innovative technologies, across multiple fields and specialties. As a company, we share a vision of improving patient outcomes and experiences and reducing costs to the health care system,” said John H. Stevens, M.D., chairman and CEO of HeartFlow. “These individuals provide the exact experience and skills needed as we prepare to become a global, commercial stage company. I am thrilled to welcome Baird, Brent, Rob and Yoshiki to the HeartFlow family.”
Baird Radford has more than 20 years of public company finance experience in Silicon Valley. Prior to joining HeartFlow, Mr. Radford served as vice president of finance at Intuitive Surgical, Inc., with responsibility for financial planning and analysis, investor relations, and enterprise analytics. Prior to Intuitive Surgical, Mr. Radford held various positions at eBay, Inc., including vice president of finance for Marketplaces Europe, as well as vice president, corporate controller, and chief accounting officer. Mr. Radford also worked in the audit practice of PricewaterhouseCoopers LLP. He received his B.B.A. from Ohio University.
Brent Ness has more than 25 years of experience in commercial and executive roles in health care. Prior to joining HeartFlow Mr. Ness served as president and chief commercial officer of ProNerve LLC, a leader in the field of Intraoperative Neurophysiological Monitoring (IOM), and as vice president of global sales and marketing for Medtronic Navigation. Prior to Medtronic, Mr. Ness held the positions of vice president of sales operations North America for Philips and corporate director of corporate accounts for GE Healthcare. He earned an M.B.A. from the University of Colorado and a B.S. from the University of North Dakota.
Robert Eno has 20 years of experience in bringing disruptive medical technologies to market. Prior to joining HeartFlow, he held the position of vice president of marketing and international sales at OptiMedica, which was acquired by Abbott. Previously, he served as vice president of marketing at NeoGuide Systems (acquired by Intuitive Surgical) and as vice president of sales and marketing at Avantec Vascular (acquired by Goodman Co. Ltd). He also held several marketing and strategic planning positions at Guidant Corporation (acquired by Abbott). He received his M.B.A. degree from Stanford University’s Graduate School of Business and his A.B. from Stanford University, where he was Phi Beta Kappa.
Yoshiki Kawabata has more than 25 years of experience in a variety of medical device businesses including surgical staplers, endoscopic devices, electrophysiology ablation products, cardiac intervention catheters, fractional flow reserve and optical coherence tomography devices and in vitro diagnostics products. Prior to joining HeartFlow, he held the position of senior director of business development and alliances at Adachi, Co., Ltd. He has held multiple roles in sales, marketing, business development, R&D, and franchise management at St. Jude Medical, Johnson & Johnson, Baxter, and Century Medical in Japan. He received his B. S. degree in Law from Rikkyo University.
Founded in 2007, HeartFlow, Inc., is a cardiovascular company based in Redwood City, Calif. A pioneer in the field of non-invasive coronary artery disease diagnosis, HeartFlow is committed to developing technology designed to help physicians noninvasively diagnose coronary artery disease and improve patient outcomes while reducing health care costs. For more information visit www.heartflow.com.